Skip to main content

Table 4 Description of MACE

From: Evaluation of therapy management and outcome in Takotsubo syndrome

Kaplan-Meier estimation

  

estimated rate (95%-confidence interval)

 

MACE

 

24 months

36 months

Total events

9 (12%)

12.5 (6.4–23.5)

15.3 (8.0–28.0)

Death

4 (5.6%)

4.6 (1.5–13.5)

7.6 (2.8–20.3)

Stroke

3 (4.2%)

4.9 (1.6–14.7)

4.9 (1.6–14.7)

MI/TTS

2 (2.8%)

3.5 (0.9–13.6)

3.5 (0.9–13.6)

  1. Data is presented as number of patients and percentage. Estimated event rates are presented with Kaplan-Meier estimation after 24 and 36 months
  2. MACE major adverse clinical events, MI myocardial infarction, TTS Takotsubo syndrome